Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families  Nicholas J. Taylor, Nandita Mitra, Alisa M. Goldstein,

Slides:



Advertisements
Similar presentations
David L. Duffy, Mark M. Iles, Dan Glass, Gu Zhu, Jennifer H
Advertisements

All-Cause and Cause-Specific Mortality in Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study  Meng-Sui Lee, Yi-Chun Yeh, Yun-Ting.
Jakub Tolar, Johann W. Bauer, Daniel H. Kaplan, Sancy A
Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness  Shenying Fang, Amaury Vaysse, Myriam Brossard,
Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness  Shenying Fang, Amaury Vaysse, Myriam Brossard,
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial  Hywel C. Williams,
Skills training after night shift work enables acquisition of endovascular technical skills on a virtual reality simulator  Peter A. Naughton, MD, Rajesh.
Primary Melanoma Tumors from CDKN2A Mutation Carriers Do Not Belong to a Distinct Molecular Subclass  Johan Staaf, Katja Harbst, Martin Lauss, Markus.
Expanding Our Understanding of Human Skin Aging
Skin-Derived Vitamin D3 Protects against Basal Cell Carcinoma
Jianxin Shi, Weiyin Zhou, Bin Zhu, Paula L
Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities  Martin Lauss, Jeremie Nsengimana, Johan Staaf, Julia Newton-Bishop, Göran.
Karin Greveling, Marlies Wakkee, Tamar Nijsten, Renate R
Michael R. Williams, Richard L. Gallo 
Clinical Snippets Journal of Investigative Dermatology
Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma  Rachel D. Melamed, Iraz T. Aydin, Geena Susan Rajan, Robert.
Placebo Effects on Itch: A Meta-Analysis of Clinical Trials of Patients with Dermatological Conditions  Antoinette I.M. van Laarhoven, Ineke M. van der.
The absence of multiple atypical nevi in germline CDKN2A mutations: Comment on “Hereditary melanoma: Update on syndromes and management: Genetics of familial.
Luigi Naldi  Journal of Investigative Dermatology 
Outcomes and Risk Factors in Patients with Multiple Primary Melanomas
The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031  David C.
Databases for Clinical Research
Joanne E. Sordillo, Peter Kraft, Ann Chen Wu, Maryam M. Asgari 
Clinical Snippets Journal of Investigative Dermatology
Research Techniques Made Simple: Cost-Effectiveness Analysis
Global Associations between UVR Exposure and Current Eczema Prevalence in Children from ISAAC Phase Three  Elaine Fuertes, Carsten Flohr, Jonathan I.
Brooke–Spiegler Syndrome Locus Assigned to 16q12-q13
Recent Trends in Incidence of Cutaneous Melanoma among US Caucasian Young Adults  Mark P. Purdue, Laura E. Beane Freeman, William F. Anderson, Margaret.
Peter B. Cserhalmi-Friedman, Maria C
Toward Improved Understanding of a Potential Association between Isotretinoin and Inflammatory Bowel Disease  Alisa N. Femia, Ruth Ann Vleugels  Journal.
Circulating Tumor Cells and Melanoma Progression
Tamar Nijsten  Journal of Investigative Dermatology 
Maria Erali, David C. Pattison, Carl T. Wittwer, Cathy A. Petti 
Hywel C. Williams, Barbara A. Gilchrest 
More Than Many: How to Manage the Most Frequent Cancer?
Teledermatology in China: History, Current Status, and the Next Step
Minutes of the Board of Directors Meeting
Journal of Investigative Dermatology
Star Trek Publishing Journal of Investigative Dermatology
Remco van Doorn, Willem H. Zoutman, Nelleke A. Gruis 
Clinical Snippets Journal of Investigative Dermatology
Sigrun A.J. Schmidt, Serigne Lo, Loes M. Hollestein 
Research Techniques Made Simple: Itch Measurement in Clinical Trials
Journal of Investigative Dermatology
Journal of Investigative Dermatology 
Research Techniques Made Simple: Bioinformatics for Genome-Scale Biology  Amy C. Foulkes, David S. Watson, Christopher E.M. Griffiths, Richard B. Warren,
Society for Investigative Dermatology 2010 Meeting Minutes
Journal of Investigative Dermatology
Erratum Journal of Investigative Dermatology
Research Snippets Journal of Investigative Dermatology
Reviewer Acknowledgment
BJD Editor’s Choice Journal of Investigative Dermatology
Metabolic Vulnerability in Melanoma: A ME2 (Me Too) Story
Research Snippets from the British Journal of Dermatology
A Large Mutational Study in Pachyonychia Congenita
Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma  Linda Gao, Karin van den Hurk, Jérémie Nsengimana,
Clinical and Molecular Characterization of Patients at Risk for Hereditary Melanoma in Southern Brazil  Patricia Ashton-Prolla, Lucio Bakos, Gerson Junqueira,
Journal of Investigative Dermatology
Activated protein C-protein C inhibitor complex: A new biological marker for aortic aneurysms  Tilo Kölbel, MD, Karin Strandberg, MD, PhD, Ingrid Mattiasson,
Journal of Investigative Dermatology
Conceptual Issues in Measuring the Burden of Skin Diseases
Rachel C. Wachsmuth, Faye Turner, Jennifer H
Marie-Louise T. Johnson 
A Quality-of-Life Study in High-Risk (Thickness≥2 mm) Cutaneous Melanoma Patients in a Randomized Trial of 1-cm versus 3-cm Surgical Excision Margins 
CDKN2A and MC1R Mutations in Patients with Sporadic Multiple Primary Melanoma  Ketty Peris, Maria Concetta Fargnoli, Alessia Pacifico, Tiziana Surrenti,
CDKN2A: The IVS2-105A/G Intronic Mutation Found in an Italian Patient Affected by Eight Primary Melanomas  Silvia Majore, Caterina Catricalà, Francesco.
Failure to Detect Differences in Proliferation Status of Nevi from CDKN2A Mutation Carriers and Non-Carriers  Scott R. Florell, Kenneth M. Boucher, Joseph.
Journal of Investigative Dermatology
Journal of Investigative Dermatology
Excess Cancer Mortality in Six Dutch Pedigrees with the Familial Atypical Multiple Mole- Melanoma Syndrome from 1830 to 1994  Elysée T.M. Hille, Erik van.
Presentation transcript:

Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families  Nicholas J. Taylor, Nandita Mitra, Alisa M. Goldstein, Margaret A. Tucker, Marie-Françoise Avril, Esther Azizi, Wilma Bergman, D. Timothy Bishop, Brigitte Bressac-de Paillerets, William Bruno, Donato Calista, Lisa A. Cannon-Albright, Francisco Cuellar, Anne E. Cust, Florence Demenais, David E. Elder, Anne-Marie Gerdes, Paola Ghiorzo, Thais C. Grazziotin, Johan Hansson, Mark Harland, Nicholas K. Hayward, Marko Hocevar, Veronica Höiom, Christian Ingvar, Maria Teresa Landi, Gilles Landman, Alejandra Larre-Borges, Sancy A. Leachman, Graham J. Mann, Eduardo Nagore, Håkan Olsson, Jane M. Palmer, Barbara Perić, Dace Pjanova, Antonia Pritchard, Susana Puig, Nienke van der Stoep, Karin A.W. Wadt, Linda Whitaker, Xiaohong R. Yang, Julia A. Newton Bishop, Nelleke A. Gruis, Peter A. Kanetsky  Journal of Investigative Dermatology  Volume 137, Issue 12, Pages 2606-2612 (December 2017) DOI: 10.1016/j.jid.2017.07.829 Copyright © 2017 The Authors Terms and Conditions

Figure 1 2-mm, 5-mm, and atypical nevus count distributions among GenoMEL melanoma family members across all ascertainment centers according to CDKN2A mutational status. Crude nevus counts are plotted and are not representative of center-specific measures adopted for statistical modeling. Heavy horizonal lines indicate 50th percentile counts, boxes indicate 25th and 75th percentile counts, whiskers indicate 5th and 95th percentile counts, and circles represent values in the top 5% of counts. Journal of Investigative Dermatology 2017 137, 2606-2612DOI: (10.1016/j.jid.2017.07.829) Copyright © 2017 The Authors Terms and Conditions